Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

Applying a DNA vaccine to skin with active hair growth boosts immune response and protection against anthrax in mice.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

FGF5 spliceosomes inhibit rabbit hair growth by affecting gene expression.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Adding low-level light therapy to minoxidil improves hair growth and patient satisfaction.

HYDRO DELUXE BIO hyaluronic acid hydrogel is compatible with skin cells, may reduce inflammation, promote blood vessel growth, and protect against oxidative stress, suggesting it could help revitalize hair follicles.

EDA signaling is linked to skin disorders, various cancers, and liver disease.

Caffeine may benefit skin and hair health but more research is needed to confirm its effectiveness in dermatology.

Platelet-rich plasma (PRP) shows promise in skin and hair treatments but results vary with preparation methods.

PRP injections did not significantly improve hair growth in men with androgenetic alopecia.

Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.

CO2 laser-associated PDT effectively treated therapy-resistant folliculitis decalvans.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

The back of the scalp has more nerve fibers than the front, which may explain why some people feel more sensitivity there.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Current treatments for androgenetic alopecia manage symptoms but don't cure it, and it affects social and psychological well-being.

The document concludes that non-endocrine alopecia in pets varies in treatment effectiveness and often has a poor prognosis, especially in cats.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

CD2 might be a new treatment target for patchy alopecia areata.

Oral clindamycin and rifampicin are the most effective treatments for Folliculitis decalvans.

A lotion with minoxidil, hydrocortisone butyrate, and 17a-estradiol can improve or stabilize Frontal Fibrosing Alopecia in some cases, but there's no universally-accepted treatment yet.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.